Literature DB >> 31512783

A basal-enriched microRNA is required for prostate tumorigenesis in a Pten knockout mouse model.

Xiying Fan1, Glen A Bjerke1, Kent Riemondy1, Li Wang1, Rui Yi1.   

Abstract

MicroRNAs (miRNAs) play important roles in prostate cancer development. However, it remains unclear how individual miRNAs contribute to the initiation and progression of prostate cancer. Here we show that a basal layer-enriched miRNA is required for prostate tumorigenesis. We identify miR-205 as the most highly expressed miRNA and enriched in the basal cells of the prostate. Although miR-205 is not required for normal prostate development and homeostasis, genetic deletion of miR-205 in a Pten null tumor model significantly compromises tumor progression and does not promote metastasis. In Pten null basal cells, loss of miR-205 attenuates pAkt levels and promotes cellular senescence. Furthermore, although overexpression of miR-205 in prostate cancer cells with luminal phenotypes inhibits cell growth in both human and mouse, miR-205 has a minimal effect on the growth of a normal human prostate cell line. Taken together, we have provided genetic evidence for a requirement of miR-205 in the progression of Pten null-induced prostate cancer.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  PI(3)K pathway; miRNAs; prostate cancer

Mesh:

Substances:

Year:  2019        PMID: 31512783      PMCID: PMC7791532          DOI: 10.1002/mc.23112

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  29 in total

1.  Cell-type-specific signatures of microRNAs on target mRNA expression.

Authors:  Pranidhi Sood; Azra Krek; Mihaela Zavolan; Giuseppe Macino; Nikolaus Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

2.  Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes.

Authors:  C W Gregory; K G Hamil; D Kim; S H Hall; T G Pretlow; J L Mohler; F S French
Journal:  Cancer Res       Date:  1998-12-15       Impact factor: 12.701

3.  Integrative genomic profiling of human prostate cancer.

Authors:  Barry S Taylor; Nikolaus Schultz; Haley Hieronymus; Anuradha Gopalan; Yonghong Xiao; Brett S Carver; Vivek K Arora; Poorvi Kaushik; Ethan Cerami; Boris Reva; Yevgeniy Antipin; Nicholas Mitsiades; Thomas Landers; Igor Dolgalev; John E Major; Manda Wilson; Nicholas D Socci; Alex E Lash; Adriana Heguy; James A Eastham; Howard I Scher; Victor E Reuter; Peter T Scardino; Chris Sander; Charles L Sawyers; William L Gerald
Journal:  Cancer Cell       Date:  2010-06-24       Impact factor: 31.743

4.  The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis.

Authors:  Li Xin; Devon A Lawson; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-28       Impact factor: 11.205

5.  In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes.

Authors:  Chen Li Chew; Andrea Lunardi; Federico Gulluni; Daniel T Ruan; Ming Chen; Leonardo Salmena; Michiya Nishino; Antonella Papa; Christopher Ng; Jacqueline Fung; John G Clohessy; Junko Sasaki; Takehiko Sasaki; Roderick T Bronson; Emilio Hirsch; Pier Paolo Pandolfi
Journal:  Cancer Discov       Date:  2015-04-16       Impact factor: 39.397

6.  Dicer ablation impairs prostate stem cell activity and causes prostate atrophy.

Authors:  Li Zhang; Boyu Zhang; Joseph M Valdez; Fen Wang; Michael Ittmann; Li Xin
Journal:  Stem Cells       Date:  2010-07       Impact factor: 6.277

7.  Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse.

Authors:  A Di Cristofano; M De Acetis; A Koff; C Cordon-Cardo; P P Pandolfi
Journal:  Nat Genet       Date:  2001-02       Impact factor: 38.330

8.  Pten dose dictates cancer progression in the prostate.

Authors:  Lloyd C Trotman; Masaru Niki; Zohar A Dotan; Jason A Koutcher; Antonio Di Cristofano; Andrew Xiao; Alan S Khoo; Pradip Roy-Burman; Norman M Greenberg; Terry Van Dyke; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  PLoS Biol       Date:  2003-10-27       Impact factor: 8.029

9.  MicroRNA-205 controls neonatal expansion of skin stem cells by modulating the PI(3)K pathway.

Authors:  Dongmei Wang; Zhaojie Zhang; Evan O'Loughlin; Li Wang; Xiying Fan; Eric C Lai; Rui Yi
Journal:  Nat Cell Biol       Date:  2013-08-25       Impact factor: 28.824

10.  Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion.

Authors:  Guocan Wang; Andrea Lunardi; Jiangwen Zhang; Zhenbang Chen; Ugo Ala; Kaitlyn A Webster; Yvonne Tay; Enrique Gonzalez-Billalabeitia; Ainara Egia; David R Shaffer; Brett Carver; Xue-Song Liu; Riccardo Taulli; Winston Patrick Kuo; Caterina Nardella; Sabina Signoretti; Carlos Cordon-Cardo; William L Gerald; Pier Paolo Pandolfi
Journal:  Nat Genet       Date:  2013-06-02       Impact factor: 38.330

View more
  1 in total

Review 1.  MicroRNAs as Guardians of the Prostate: Those Who Stand before Cancer. What Do We Really Know about the Role of microRNAs in Prostate Biology?

Authors:  Thomas Andl; Kavya Ganapathy; Alexia Bossan; Ratna Chakrabarti
Journal:  Int J Mol Sci       Date:  2020-07-07       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.